Extraperitoneal response to intraperitoneal immunotherapy with catumaxomab in a patient with cutaneous lymphangiosis carcinomatosa from ovarian cancer: a case report and review of the literature.

Med Oncol

Department of Gynecology, European Competence Center for Ovarian Cancer, Charité-Campus Virchow Klinikum, Medical University of Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

Published: December 2012

Cutaneous metastasation is a very rare manifestation of ovarian cancer. We present the case of a 64-year-old woman with recurrent platinum-refractory ovarian cancer and skin metastasis. The patient was treated with intraperitoneal catumaxomab due to massive refractory malignant ascites. Clinical response of the skin metastasis was observed during the intraperitoneal treatment with catumaxomab. Even though response of extraperitoneal tumor sites can be explained with intravascular uptake and a possible vaccination effect, this phenomenon has not been reported up to this point to the best of our knowledge.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-012-0285-xDOI Listing

Publication Analysis

Top Keywords

ovarian cancer
12
cancer case
8
skin metastasis
8
extraperitoneal response
4
response intraperitoneal
4
intraperitoneal immunotherapy
4
immunotherapy catumaxomab
4
catumaxomab patient
4
patient cutaneous
4
cutaneous lymphangiosis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!